SCHEMBL9271353

SCHEMBL9271353

CC(=O)N1C(C(=O)c2cn(C(=O)N(C)C)c3ccccc23)CSC1c1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9256489 0.92 — —
SCHEMBL9264741 0.90 — —
SCHEMBL9256441 0.87 — —
SCHEMBL9264693 0.86 — —
SCHEMBL9270504 0.85 — —
SCHEMBL9257768 0.85 — —
SCHEMBL9269009 0.79 — —
SCHEMBL9271530 0.78 — —
SCHEMBL9266521 0.78 — —
SCHEMBL9257590 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0574494-A4 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LAB (US) 1994-07-06 — — EP claimed
EP-0574494-A1 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1993-12-22 — — EP claimed
WO-1992014732-A1 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1992-09-03 — — WO claimed
EP-0499987-A1 Platelet activating factor antagonists ABBOTT LABORATORIES (US) 1992-08-26 — — EP claimed
US-5382670-A Platelet activating factor antagonists ABBOTT LABORATORIES (US) 1995-01-17 — — US disclosed
EP-0499987-A1 Platelet activating factor antagonists ABBOTT LABORATORIES (US) 1992-08-26 — — EP disclosed
Send feedback